SCOTUS ruling on confidential sales: lawyers comment
US Supreme Court says confidential sales can invoke on-sale bar
phototechno / iStockphoto.com
The US Supreme Court will today hear a patent dispute between Helsinn Healthcare and Teva Pharmaceuticals, with lawyers telling WIPR that the probable reversal in the case will have a wide-ranging impact.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
US Supreme Court, patentability, America Invents Act, Teva, Helsinn, on-sale bar, patent invalidation, Aloxi, palonosetron hydrochloride, statutory meaning